Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Bausch and Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (’Pink Eye’)

May 28th, 2009
by admin.

Besivance Adds to Bausch & Lomb’s Expanding Ocular Pharmaceuticals Portfolio and Offers New Therapeutic Option for a Wide Range of Ocular Bacterial Pathogens(1) MADISON, N.J., May 29 (HSMN NewsFeed) — Bausch & Lomb, a world leader in eye health, toda…
Biopharmaceuticals, Ophthalmology, FDA
Bausch & Lomb, Besivance, besifloxacin, pink eye, conjunctivitis

Bausch and Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (’Pink Eye’)

Posted in: Medical Sales Jobs.

← FDA Approves SBi’s S.T.A.R. Total Ankle Replacement System
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe →

0 Comments on “Bausch and Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (’Pink Eye’)”

Leave a Comment